ARVINAS, INC. Collaboration Agreements
7 Contracts & Agreements
- Amendment No. 3 to Research Collaboration and License Agreement between Pfizer Inc. and Arvinas Operations, Inc (formerly Arvinas, Inc.), dated December 21, 2022 (Filed With SEC on February 23, 2023)
- Amendment No. 2 to Research Collaboration and License Agreement between Pfizer Inc. and Arvinas Operations, Inc. (formerly Arvinas, Inc.), dated January 14, 2022 (Filed With SEC on May 5, 2022)
- Collaboration Agreement, dated July 21, 2021, by and between Arvinas, Inc., Arvinas Operations, Inc., Arvinas Estrogen Receptor, Inc. and Pfizer, Inc (Filed With SEC on July 22, 2021)
- Amendment No. 1 to Research Collaboration and License Agreement between Pfizer Inc. and Arvinas Operations, Inc. (formerly Arvinas, Inc.), dated December 9, 2019 (Filed With SEC on March 16, 2020)
- Collaboration and License Agreement between Arvinas Operations, Inc. and Bayer AG, dated June 3, 2019 (Filed With SEC on August 5, 2019)
- Research Collaboration and License Agreement between Pfizer Inc. and Arvinas, Inc., dated December 22, 2017 (Filed With SEC on September 14, 2018)
- Research Collaboration and License Agreement between Pfizer Inc. and Arvinas, Inc., dated December 22, 2017 (Filed With SEC on August 30, 2018)
